METRELEPTIN for Partial lipodystrophy: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 51 adverse event reports in the FDA FAERS database where METRELEPTIN was used for Partial lipodystrophy.
Most Reported Side Effects for METRELEPTIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Therapy cessation | 94 | 8.3% | 7 | 42 |
| Product dose omission issue | 88 | 7.8% | 2 | 22 |
| Weight decreased | 88 | 7.8% | 2 | 20 |
| Blood glucose increased | 77 | 6.8% | 0 | 21 |
| Drug ineffective | 69 | 6.1% | 3 | 15 |
| Therapy interrupted | 65 | 5.7% | 2 | 35 |
| Nausea | 57 | 5.0% | 2 | 22 |
| Off label use | 51 | 4.5% | 8 | 23 |
| Blood triglycerides increased | 49 | 4.3% | 0 | 19 |
| Treatment noncompliance | 49 | 4.3% | 4 | 24 |
| Weight increased | 45 | 4.0% | 0 | 9 |
| Decreased appetite | 43 | 3.8% | 2 | 12 |
| Injection site pain | 42 | 3.7% | 1 | 4 |
| Maternal exposure during pregnancy | 41 | 3.6% | 0 | 1 |
| Hypoglycaemia | 40 | 3.5% | 2 | 12 |
Other Indications for METRELEPTIN
Lipodystrophy acquired (477)
Congenital generalised lipodystrophy (394)
Product used for unknown indication (97)
Familial partial lipodystrophy (58)
Acquired generalised lipodystrophy (36)
Lipoatrophy (16)
Non-alcoholic steatohepatitis (9)
Diabetes mellitus (6)
Hypertriglyceridaemia (6)